DMAAU logo

Drugs Made In America Acquisition Corp. (DMAAU)

Profile

Full Name

Drugs Made In America Acquisition Corp.

Ticker

NASDAQ: DMAAU

Exchange

NASDAQ

Sector

Financial Services

Industry

Shell Companies

Country

United States

IPO

January 27, 2025

Indexes

Not included

Website

https://dmaacorp.com

Employees

2

Key Details

Price

$10.56

Market cap

$308.05M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

$0.00(0.00% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $10.56
    DMAAU price is $10.56

    30-Day Relative Volume

    2.17
    DMAAU 30-day relative volume is 2.17

    Price Performance

    Price Most recent change

    -
    DMAAU price change on Sep 16, 2025 is unknown

    Price YTD change

    -
    DMAAU price ytd change is unknown

    Price 1-year change

    -
    DMAAU price 1-year change is unknown

    Price 3-year change

    -
    DMAAU price 3-year change is unknown

    Price Range

    Price All-time high

    $10.82
    DMAAU price is currently -2.40% below its historical high of $10.82

    Price 3-year low

    $10.00
    DMAAU price is currently +5.60% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $308.05M
    DMAAU market capitalization is $308.05 million

    Market cap 3-year change

    -
    DMAAU market capitalization 3-year change is unknown

    Market cap All-time high

    $309.22M
    DMAAU market capitalization is currently -0.38% below its historical high of $309.22 million

    Market cap sector rank

    39.34%
    DMAAU market capitalization is higher than 39.34% of companies in Financial Services sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    DMAAU shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    -
    DMAAU shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.02
    DMAAU beta is 0.02

    200-day SMA

    $10.23
    DMAAU price is currently +3.20% above its 200-day simple moving average

    50-day SMA

    $10.38
    DMAAU price is currently +1.71% above its 50-day simple moving average

    RSI

    56.87
    DMAAU 14-day relative strength index is 56.87

    Volume

    2.17
    DMAAU 30-day relative volume is 2.17

    ATR

    $0.02
    DMAAU average true range is $0.02

    10-day Historical Volatility

    10.13%
    DMAAU 10-day historical volatility is 10.13%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    DMAAU annual revenue is $0.00

    Revenue Analysts estimate

    -
    DMAAU annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    DMAAU annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    -
    DMAAU annual revenue is unknown

    EPS

    EPS

    $0.00
    DMAAU annual earnings per share is $0.00

    EPS Analysts estimate

    -
    DMAAU annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    0%
    DMAAU annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    -
    DMAAU annual earnings per share is unknown

    Profit

    Gross profit

    $0.00
    DMAAU annual gross profit is $0.00

    Gross margin

    -
    DMAAU annual gross profit margin value is unknown

    Operating profit

    -$279.80K
    DMAAU annual operating income is -$279.80 thousand

    Operating margin

    -
    DMAAU annual operating profit margin value is unknown

    Net income

    -$279.80K
    DMAAU annual net profit is -$279.80 thousand

    Net margin

    -
    DMAAU annual net profit margin value is unknown

    Expenses

    Total expenses

    $279.80K
    DMAAU annual total expenses is $279.80 thousand

    Operating expenses

    $279.80K
    DMAAU annual total operating expenses is $279.80 thousand

    Cost of goods sold

    $0.00
    DMAAU annual cost of goods sold is $0.00

    Selling, general & administrative expenses

    $0.00
    DMAAU annual SGA is $0.00

    Depreciation and amortization

    -
    DMAAU annual depreciation & amortization value is unknown

    Interest expense

    $0.00
    DMAAU annual interest expense is $0.00

    Income tax

    $0.00
    DMAAU annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$279.80K
    DMAAU annual earnings before interest & taxes is -$279.80 thousand

    EBITDA

    -$279.80K
    DMAAU annual EBITDA is -$279.80 thousand

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $550.80K
    DMAAU annual total assets is $550.80 thousand

    Non current assets

    $545.80K
    DMAAU annual long term assets is $545.80 thousand

    Current assets

    $5000.00
    DMAAU annual total current assets is $5000.00

    Cash and cash equivalents

    $1400.00
    DMAAU annual cash & cash equivalents is $1400.00

    Accounts receivable

    -
    DMAAU annual accounts receivable value is unknown

    Inventory

    $0.00
    DMAAU annual inventory is $0.00

    Liabilities

    Total liabilities

    $795.70K
    DMAAU annual total liabilities is $795.70 thousand

    Long term liabilities

    $0.00
    DMAAU annual total long term liabilities is $0.00

    Current liabilities

    $795.70K
    DMAAU annual total current liabilities is $795.70 thousand

    Accounts payable

    $0.00
    DMAAU annual accounts payable is $0.00

    Debt

    Total debt

    $662.30K
    DMAAU annual total debt is $662.30 thousand

    Total debt 1-year change

    0%
    DMAAU annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    DMAAU annual long term debt is $0.00

    Short term debt

    $662.30K
    DMAAU annual short term debt is $662.30 thousand

    Equity & Capital

    Shareholders equity

    -$244.80K
    DMAAU annual stockholders equity is -$244.80 thousand

    Book value

    -$244.80K
    DMAAU annual book value is -$244.80 thousand

    Retained earnings

    -$279.80K
    DMAAU annual retained earnings is -$279.80 thousand

    Working capital

    -$790.70K
    DMAAU annual working capital is -$790.70 thousand

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$172.30K
    DMAAU annual cash flow from operations is -$172.30 thousand

    Cash from operations 1-year change

    0%
    DMAAU annual cash flow from operations has remained unchanged year-on-year

    Cash from investing

    $0.00
    DMAAU annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    0%
    DMAAU annual cash flow from investing activities has remained unchanged year-on-year

    Cash from financing

    $173.60K
    DMAAU annual cash flow from financing activities is $173.60 thousand

    Cash from financing 1-year change

    0%
    DMAAU annual cash flow from financing activities has remained unchanged year-on-year

    CAPEX

    CAPEX

    $0.00
    DMAAU annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    DMAAU annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$172.30K
    DMAAU annual free cash flow is -$172.30 thousand

    Free cash flow 1-year change

    0%
    DMAAU annual free cash flow has remained unchanged year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    DMAAU annual gross profit margin value is unknown

    Operating margin

    -
    DMAAU annual operating profit margin value is unknown

    Net margin

    -
    DMAAU annual net profit margin value is unknown

    ROA & ROE

    ROA

    -50.80%
    DMAAU annual return on assets is -50.80%

    ROE

    114.30%
    DMAAU annual return on equity is 114.30%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DMAAU price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DMAAU price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.35
    DMAAU price to book ratio is 1.35

    PB ratio Sector rank

    56.56%
    DMAAU price to book ratio is higher than 56.56% of companies in Financial Services sector

    PS Ratio

    PS ratio

    -
    DMAAU price to sales ratio value is unknown

    PS ratio Sector rank

    -
    DMAAU price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $308.05M
    DMAAU enterprise value is $308.05 million

    Enterprise value Sector rank

    36.28%
    DMAAU enterprise value is higher than 36.28% of companies in Financial Services sector

    EV/EBITDA

    EV/EBITDA

    -447.94
    DMAAU EV/EBITDA is -447.94

    EV/EBITDA Sector rank

    16.2%
    DMAAU EV/EBITDA is higher than 16.2% of companies in Financial Services sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.01
    DMAAU annual current ratio is 0.01

    Quick ratio

    0.01
    DMAAU annual quick ratio is 0.01

    Leverage

    Debt to equity

    -2.71
    DMAAU annual debt to equity ratio is -2.71

    Interest coverage ratio

    -
    DMAAU annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    DMAAU piotroski f-score value is unknown

    Altman Z-Score

    228.18
    DMAAU altman z-score is 228.18

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with DMAAU included

    US stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    All stocks
    Financial services sector
    High Altman Z score stocks
    NASDAQ Listed Companies
    Ex Dividend dates calendar
    Small cap stocks
    Shell Companies
    • What is the ticker symbol for Drugs Made In America Acquisition Corp.?
    • Does Drugs Made In America Acquisition Corp. pay dividends?
    • What sector is Drugs Made In America Acquisition Corp. in?
    • What industry is Drugs Made In America Acquisition Corp. in?
    • What country is Drugs Made In America Acquisition Corp. based in?
    • When did Drugs Made In America Acquisition Corp. go public?
    • Is Drugs Made In America Acquisition Corp. in the S&P 500?
    • Is Drugs Made In America Acquisition Corp. in the NASDAQ 100?
    • Is Drugs Made In America Acquisition Corp. in the Dow Jones?
    • When was Drugs Made In America Acquisition Corp.'s last earnings report?
    • When does Drugs Made In America Acquisition Corp. report earnings?

    What is the ticker symbol for Drugs Made In America Acquisition Corp.?

    The ticker symbol for Drugs Made In America Acquisition Corp. is NASDAQ:DMAAU

    Does Drugs Made In America Acquisition Corp. pay dividends?

    No, Drugs Made In America Acquisition Corp. does not pay dividends

    What sector is Drugs Made In America Acquisition Corp. in?

    Drugs Made In America Acquisition Corp. is in the Financial Services sector

    What industry is Drugs Made In America Acquisition Corp. in?

    Drugs Made In America Acquisition Corp. is in the Shell Companies industry

    What country is Drugs Made In America Acquisition Corp. based in?

    Drugs Made In America Acquisition Corp. is headquartered in United States

    When did Drugs Made In America Acquisition Corp. go public?

    Drugs Made In America Acquisition Corp.'s initial public offering (IPO) was on January 27, 2025

    Is Drugs Made In America Acquisition Corp. in the S&P 500?

    No, Drugs Made In America Acquisition Corp. is not included in the S&P 500 index

    Is Drugs Made In America Acquisition Corp. in the NASDAQ 100?

    No, Drugs Made In America Acquisition Corp. is not included in the NASDAQ 100 index

    Is Drugs Made In America Acquisition Corp. in the Dow Jones?

    No, Drugs Made In America Acquisition Corp. is not included in the Dow Jones index

    When was Drugs Made In America Acquisition Corp.'s last earnings report?

    Drugs Made In America Acquisition Corp.'s most recent earnings report was on August 29, 2025

    When does Drugs Made In America Acquisition Corp. report earnings?

    The date for Drugs Made In America Acquisition Corp.'s next earnings report has not been announced yet
    On this page